Compare TCGL & SEER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TCGL | SEER |
|---|---|---|
| Founded | 2015 | 2017 |
| Country | Singapore | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Medicinal Chemicals and Botanical Products |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 109.5M | 98.2M |
| IPO Year | 2025 | 2020 |
| Metric | TCGL | SEER |
|---|---|---|
| Price | $172.84 | $1.81 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 1.8M | 145.9K |
| Earning Date | 02-17-2026 | 02-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $2,580,927.00 | ★ $16,376,999.00 |
| Revenue This Year | N/A | $22.37 |
| Revenue Next Year | N/A | $30.00 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 7.80 | ★ 12.11 |
| 52 Week Low | $3.95 | $1.62 |
| 52 Week High | $355.00 | $2.41 |
| Indicator | TCGL | SEER |
|---|---|---|
| Relative Strength Index (RSI) | 99.54 | 36.38 |
| Support Level | $8.33 | $1.84 |
| Resistance Level | $9.18 | $1.84 |
| Average True Range (ATR) | 23.43 | 0.05 |
| MACD | 13.92 | -0.01 |
| Stochastic Oscillator | 49.40 | 1.00 |
TechCreate Group Ltd is a technology consultancy and advanced software solution provider offering a comprehensive range of payment, cybersecurity, and digital services and solutions. It serves large institutions, financial institutions and telecommunication companies, by providing them with payment, cybersecurity, and digital solutions such as, the development of RTE, RTP, API management and other services, such as cybersecurity defense, IT infrastructure, and cloud services. Its core business areas comprise: (1) the provision of professional services, (2) the sale of software licenses and maintenance licenses, and (3) the sale of hardware solutions.
Seer Inc is a biotechnology company. The company commercializes transformative products for researchers to unlock deep, unbiased biological information. Its product, the Proteograph Product Suite (Proteograph), will leverage its proprietary engineered nanoparticle (NP) technology to provide unbiased, deep, rapid, and large-scale access across the proteome.